COVID-19 Antibody Responses In Cystic Fibrosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

COVID-19 Antibody Responses In Cystic Fibrosis — Stella

View on ClinicalTrials.gov

Recruiting

Back to COVID-19 trials

Trial locations(1 site)

Portugal

CHLN, Lisbon

Key details

Sponsor

Pilar Azevedo

Collaborators

Queen's University, Belfast, European Cystic Fibrosis Society - Clinical Trials Network

Enrollment target

~1,000 participants

Started

August 2022

Primary completion

September 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.